Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27.4M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
5.8M
-
Shares change
-
+308K
-
Total reported value, excl. options
-
$45.1M
-
Value change
-
+$2.53M
-
Number of buys
-
29
-
Number of sells
-
-22
-
Price
-
$7.77
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q4 2019
67 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q4 2019.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.8M shares
of 27.4M outstanding shares and own 21.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (861K shares), RENAISSANCE TECHNOLOGIES LLC (603K shares), Parkman Healthcare Partners LLC (601K shares), G2 Investment Partners Management LLC (575K shares), Fairpointe Capital LLC (441K shares), BlackRock Inc. (434K shares), EAM Investors, LLC (351K shares), EAM Global Investors LLC (215K shares), GEODE CAPITAL MANAGEMENT, LLC (139K shares), and OXFORD ASSET MANAGEMENT LLP (114K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.